Recent advances of liquid chromatography–(tandem) mass spectrometry in clinical and forensic toxicology — An update

Clinical Biochemistry

Volumn 49, Issue 13-14, 2016, Pages 1051-1071

  Remane, Daniela ^a   Wissenbach, Dirk K ^a   Peters, Frank T ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

Doping; Identification; Liquid chromatography; Mass spectrometry; Matrix effect; Quantification; Screening; Toxicology

Indexed keywords

POISON; PSYCHOTROPIC AGENT; RECREATIONAL DRUG;

ARTICLE; AUTOPSY; BLOOD; CLINICAL TOXICOLOGY; DOPING; DRIED BLOOD SPOT TESTING; DRUG CONTROL; ELECTROSPRAY; FORENSIC TOXICOLOGY; HAIR; HUMAN; IONIZATION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETER; NONHUMAN; PLASMA; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; REFERENCE DATABASE; REVERSED PHASE LIQUID CHROMATOGRAPHY; SCREENING; SERUM; TANDEM MASS SPECTROMETRY; TISSUES; TOXICOLOGY; URINE; VALIDATION STUDY; PROCEDURES;

CHROMATOGRAPHY, LIQUID; FORENSIC TOXICOLOGY; HUMANS; PSYCHOTROPIC DRUGS; TANDEM MASS SPECTROMETRY;

EID: 84991576467     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2016.07.010     Document Type: Article

References (183)

1. [1] EMCDDA-Europol, Emcdda-europol 2014 annual report on the implementation of council decision 2005/387/jha. 2014, EMCDDA-Europol.
2. [2] Peters, F.T., Recent advances of liquid chromatography-(tandem) mass spectrometry in clinical and forensic toxicology. Clin. Biochem. 44 (2011), 54–65.
3. [3] Oberacher, H., Arnhard, K., Compound identification in forensic toxicological analysis with untargeted lc-ms-based techniques. Bioanalysis 7 (2015), 2825–2840.
4. [4] Meyer, M.R., Helfer, A.G., Maurer, H.H., Current position of high-resolution ms for drug quantification in clinical & forensic toxicology. Bioanalysis 6 (2014), 2275–2284.
5. [5] Beck, O., Ericsson, M., Methods for urine drug testing using one-step dilution and direct injection in combination with lc-ms/ms and lc-hrms. Bioanalysis 6 (2014), 2229–2244.
6. [6] Maurer, H.H., What is the future of (ultra) high performance liquid chromatography coupled to low and high resolution mass spectrometry for toxicological drug screening?. J. Chromatogr. A 1292 (2013), 19–24.
7. [7] Wu, A.H., Gerona, R., Armenian, P., French, D., Petrie, M., Lynch, K.L., Role of liquid chromatography-high-resolution mass spectrometry (lc-hr/ms) in clinical toxicology. Clin. Toxicol. (Phila.) 50 (2012), 733–742.
8. [8] Viette, V., Hochstrasser, D., Fathi, M., Lc-ms (/ms) in clinical toxicology screening methods. CHIMIA Int. J. Chem. 66 (2012), 339–342.
9. [9] Saar, E., Beyer, J., Gerostamoulos, D., Drummer, O.H., The analysis of antipsychotic drugs in human matrices using lc-ms(/ms). Drug Test. Anal. 4 (2012), 376–394.
10. [10] Meyer, G.M., Maurer, H.H., Meyer, M.R., Multiple stage ms in analysis of plasma, serum, urine and in vitro samples relevant to clinical and forensic toxicology. Bioanalysis, 2016.
11. [11] Namera, A., Kawamura, M., Nakamoto, A., Saito, T., Nagao, M., Comprehensive review of the detection methods for synthetic cannabinoids and cathinones. Forensic Toxicol. 33 (2015), 175–194.
12. [12] Peters, F.T., Recent developments in urinalysis of metabolites of new psychoactive substances using lc-ms. Bioanalysis 6 (2014), 2083–2107.
13. [13] Ibáñez, M., Sancho, J.V., Bijlsma, L., van Nuijs, A.L.N., Covaci, A., Hernández, F., Comprehensive analytical strategies based on high-resolution time-of-flight mass spectrometry to identify new psychoactive substances. TrAC Trends Anal. Chem. 57 (2014), 107–117.
14. [14] Wille, S.M., Baumgartner, M.R., Fazio, V.D., Samyn, N., Kraemer, T., Trends in drug testing in oral fluid and hair as alternative matrices. Bioanalysis 6 (2014), 2193–2209.
15. [15] Barroso, M., Gallardo, E., Hair analysis for forensic applications: Is the future bright?. Bioanalysis 6 (2014), 1–3.
16. [16] Thevis, M., Thomas, A., Schanzer, W., Targeting prohibited substances in doping control blood samples by means of chromatographic-mass spectrometric methods. Anal. Bioanal. Chem. 405 (2013), 9655–9667.
17. [17] Gosetti, F., Mazzucco, E., Gennaro, M.C., Marengo, E., Ultra high performance liquid chromatography tandem mass spectrometry determination and profiling of prohibited steroids in human biological matrices. A review. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 927 (2013), 22–36.
18. [18] Pozo, O.J., Marcos, J., Segura, J., Ventura, R., Recent developments in ms for small molecules: Application to human doping control analysis. Bioanalysis 4 (2012), 197–212.
19. [19] Thevis, M., Thomas, A., Schanzer, W., Current role of lc-ms(/ms) in doping control. Anal. Bioanal. Chem. 401 (2011), 405–420.
20. [20] Thevis, M., Thomas, A., Schanzer, W., Doping control analysis of selected peptide hormones using lc-ms(/ms). Forensic Sci. Int. 213 (2011), 35–41.
21. [21] Maurer, H.H., Position of chromatographic techniques in screening for detection of drugs or poisons in clinical and forensic toxicology and/or doping control [review]. Clin. Chem. Lab. Med. 42 (2004), 1310–1324.
22. [22] Skelton, H., Dann, L.M., Ong, R.T., Hamilton, T., Ilett, K.F., Drug screening of patients who deliberately harm themselves admitted to the emergency department. Ther. Drug Monit. 20 (1998), 98–103.
23. [23] Wu, A.H., McKay, C., Broussard, L.A., Hoffman, R.S., Kwong, T.C., Moyer, T.P., et al. National academy of clinical biochemistry laboratory medicine practice guidelines: Recommendations for the use of laboratory tests to support poisoned patients who present to the emergency department. Clin. Chem. 49 (2003), 357–379.
24. [24] Baselt, R.C., Disposition of toxic drugs and chemicals in man. nineth ed., 2011, Biomedical Publications, Seal Beach, Ca.
25. [25] Gorgens, C., Guddat, S., Orlovius, A.K., Sigmund, G., Thomas, A., Thevis, M., et al. “Dilute-and-inject” multi-target screening assay for highly polar doping agents using hydrophilic interaction liquid chromatography high resolution/high accuracy mass spectrometry for sports drug testing. Anal. Bioanal. Chem. 407 (2015), 5365–5379.
26. [26] Helfer, A.G., Michely, J.A., Weber, A.A., Meyer, M.R., Maurer, H.H., Orbitrap technology for comprehensive metabolite-based liquid chromatographic-high resolution-tandem mass spectrometric urine drug screening - exemplified for cardiovascular drugs. Anal. Chim. Acta 891 (2015), 221–233.
27. [27] Concheiro, M., Castaneto, M., Kronstrand, R., Huestis, M.A., Simultaneous determination of 40 novel psychoactive stimulants in urine by liquid chromatography-high resolution mass spectrometry and library matching. J. Chromatogr. A 1397 (2015), 32–42.
28. [28] Paul, M., Ippisch, J., Herrmann, C., Guber, S., Schultis, W., Analysis of new designer drugs and common drugs of abuse in urine by a combined targeted and untargeted lc-hr-qtofms approach. Anal. Bioanal. Chem. 406 (2014), 4425–4441.
29. [29] Li, X., Shen, B., Jiang, Z., Huang, Y., Zhuo, X., Rapid screening of drugs of abuse in human urine by high-performance liquid chromatography coupled with high resolution and high mass accuracy hybrid linear ion trap-orbitrap mass spectrometry. J. Chromatogr. A 1302 (2013), 95–104.
30. [30] Sundstrom, M., Pelander, A., Angerer, V., Hutter, M., Kneisel, S., Ojanpera, I., A high-sensitivity ultra-high performance liquid chromatography/high-resolution time-of-flight mass spectrometry (uhplc-hr-tofms) method for screening synthetic cannabinoids and other drugs of abuse in urine. Anal. Bioanal. Chem., 2013.
31. [31] Chindarkar, N.S., Wakefield, M.R., Stone, J.A., Fitzgerald, R.L., Liquid chromatography high-resolution tof analysis: Investigation of mse for broad-spectrum drug screening. Clin. Chem. 60 (2014), 1115–1125.
32. [32] Badoud, F., Grata, E., Boccard, J., Guillarme, D., Veuthey, J.L., Rudaz, S., et al. Quantification of glucuronidated and sulfated steroids in human urine by ultra-high pressure liquid chromatography quadrupole time-of-flight mass spectrometry. Anal. Bioanal. Chem. 400 (2011), 503–516.
33. [33] Scheidweiler, K.B., Jarvis, M.J., Huestis, M.A., Nontargeted swath acquisition for identifying 47 synthetic cannabinoid metabolites in human urine by liquid chromatography-high-resolution tandem mass spectrometry. Anal. Bioanal. Chem. 407 (2015), 883–897.
34. [34] de Castro, A., Gergov, M., Ostman, P., Ojanpera, I., Pelander, A., Combined drug screening and confirmation by liquid chromatography time-of-flight mass spectrometry with reverse database search. Anal. Bioanal. Chem. 403 (2012), 1265–1278.
35. [35] Crews, B.O., Pesce, A.J., West, R., Nguyen, H., Fitzgerald, R.L., Evaluation of high-resolution mass spectrometry for urine toxicology screening in a pain management setting. J. Anal. Toxicol. 36 (2012), 601–607.
36. [36] Ahrens, B.D., Kucherova, Y., Butch, A.W., Detection of stimulants and narcotics by liquid chromatography-tandem mass spectrometry and gas chromatography-mass spectrometry for sports doping control. Methods Mol. Biol. 1383 (2016), 247–263.
37. [37] Ahrens, B.D., Starcevic, B., Butch, A.W., Detection of prohibited substances by liquid chromatography tandem mass spectrometry for sports doping control. Methods Mol. Biol. 902 (2012), 115–128.
38. [38] Wohlfarth, A., Scheidweiler, K.B., Chen, X., Liu, H.F., Huestis, M.A., Qualitative confirmation of 9 synthetic cannabinoids and 20 metabolites in human urine using lc-ms/ms and library search. Anal. Chem. 85 (2013), 3730–3738.
39. [39] Wissenbach, D.K., Meyer, M.R., Remane, D., Weber, A.A., Maurer, H.H., Development of the first metabolite-based lc-ms(n) urine drug screening procedure-exemplified for antidepressants. Anal. Bioanal. Chem. 400 (2011), 79–88.
40. [40] Wissenbach, D.K., Meyer, M.R., Remane, D., Philipp, A.A., Weber, A.A., Maurer, H.H., Drugs of abuse screening in urine as part of a metabolite-based lc-msn screening concept. Anal. Bioanal. Chem. 400 (2011), 3481–3489.
41. [41] Mueller, D.M., Duretz, B., Espourteille, F.A., Rentsch, K.M., Development of a fully automated toxicological lc-ms(n) screening system in urine using online extraction with turbulent flow chromatography. Anal. Bioanal. Chem. 400 (2011), 89–100.
42. [42] Arnhard, K., Gottschall, A., Pitterl, F., Oberacher, H., Applying ‘sequential windowed acquisition of all theoretical fragment ion mass spectra' (swath) for systematic toxicological analysis with liquid chromatography-high-resolution tandem mass spectrometry. Anal. Bioanal. Chem. 407 (2015), 405–414.
43. [43] Oberacher, H., Schubert, B., Libiseller, K., Schweissgut, A., Detection and identification of drugs and toxicants in human body fluids by liquid chromatography-tandem mass spectrometry under data-dependent acquisition control and automated database search. Anal. Chim. Acta 770 (2013), 121–131.
44. [44] Montenarh, D., Hopf, M., Warth, S., Maurer, H.H., Schmidt, P., Ewald, A.H., A simple extraction and lc-ms/ms approach for the screening and identification of over 100 analytes in eight different matrices. Drug Test. Anal. 7 (2015), 214–240.
45. [45] Broecker, S., Herre, S., Wust, B., Zweigenbaum, J., Pragst, F., Development and practical application of a library of cid accurate mass spectra of more than 2,500 toxic compounds for systematic toxicological analysis by lc-qtof-ms with data-dependent acquisition. Anal. Bioanal. Chem. 400 (2011), 101–117.
46. [46] Guale, F., Shahreza, S., Walterscheid, J.P., Chen, H.H., Arndt, C., Kelly, A.T., et al. Validation of lc-tof-ms screening for drugs, metabolites, and collateral compounds in forensic toxicology specimens. J. Anal. Toxicol. 37 (2013), 17–24.
47. [47] Johnson, R.D., Botch, S.R., The screening of forensic blood, urine, and tissue specimens for xenobiotics using ion-trap liquid chromatography-tandem mass spectrometry. J. Anal. Toxicol. 35 (2011), 65–74.
48. [48] Roemmelt, A.T., Steuer, A.E., Poetzsch, M., Kraemer, T., Liquid chromatography, in combination with a quadrupole time-of-flight instrument (lc qtof), with sequential window acquisition of all theoretical fragment-ion spectra (swath) acquisition: Systematic studies on its use for screenings in clinical and forensic toxicology and comparison with information-dependent acquisition (ida). Anal. Chem. 86 (2014), 11742–11749.
49. [49] Teng, X., Liang, C., Wang, R., Sun, T., Rao, Y., Ni, C., et al. Screening of drugs of abuse and toxic compounds in human whole blood using online solid-phase extraction and high-performance liquid chromatography with time-of-flight mass spectrometry. J. Sep. Sci. 38 (2015), 50–59.
50. [50] Pasin, D., Bidny, S., Fu, S., Analysis of new designer drugs in post-mortem blood using high-resolution mass spectrometry. J. Anal. Toxicol. 39 (2015), 163–171.
51. [51] Pedersen, A.J., Dalsgaard, P.W., Rode, A.J., Rasmussen, B.S., Muller, I.B., Johansen, S.S., et al. Screening for illicit and medicinal drugs in whole blood using fully automated spe and ultra-high-performance liquid chromatography with tof-ms with data-independent acquisition. J. Sep. Sci. 36 (2013), 2081–2089.
52. [52] Rosano, T.G., Wood, M., Ihenetu, K., Swift, T.A., Drug screening in medical examiner casework by high-resolution mass spectrometry (uplc-mse-tof). J. Anal. Toxicol. 37 (2013), 580–593.
53. [53] Dalsgaard, P.W., Rode, A.J., Pedersen, A.J., Rasmussen, B.S., Windberg, C.N., Linnet, K., Screening of 30 acidic and neutral pharmaceuticals in whole blood by fully automated spe and uplc-tof-ms(e.). Drug Test. Anal. 5 (2013), 254–258.
54. [54] Roemmelt, A.T., Steuer, A.E., Kraemer, T., Liquid chromatography, in combination with a quadrupole time-of-flight instrument, with sequential window acquisition of all theoretical fragment-ion spectra acquisition: Validated quantification of 39 antidepressants in whole blood as part of a simultaneous screening and quantification procedure. Anal. Chem. 87 (2015), 9294–9301.
55. [55] Birkler, R.I., Telving, R., Ingemann-Hansen, O., Charles, A.V., Johannsen, M., Andreasen, M.F., Screening analysis for medicinal drugs and drugs of abuse in whole blood using ultra-performance liquid chromatography time-of-flight mass spectrometry (uplc-tof-ms)–toxicological findings in cases of alleged sexual assault. Forensic Sci. Int. 222 (2012), 154–161.
56. [56] Rosano, T.G., Wood, M., Swift, T.A., Postmortem drug screening by non-targeted and targeted ultra-performance liquid chromatography-mass spectrometry technology. J. Anal. Toxicol. 35 (2011), 411–423.
57. [57] Viette, V., Guillarme, D., Mylonas, R., Mauron, Y., Fathi, M., Rudaz, S., et al. A multi-target screening analysis in human plasma using fast liquid chromatography-hybrid tandem mass spectrometry (part i). Clin. Biochem. 44 (2011), 32–44.
58. [58] Viette, V., Guillarme, D., Mylonas, R., Mauron, Y., Fathi, M., Rudaz, S., et al. A multi-target screening analysis in human plasma using fast liquid chromatography-hybrid tandem mass spectrometry (part ii). Clin. Biochem. 44 (2011), 45–53.
59. [59] Huppertz, L.M., Kneisel, S., Auwarter, V., Kempf, J., A comprehensive library-based, automated screening procedure for 46 synthetic cannabinoids in serum employing liquid chromatography-quadrupole ion trap mass spectrometry with high-temperature electrospray ionization. J. Mass Spectrom. 49 (2014), 117–127.
60. [60] Kempf, J., Traber, J., Auwarter, V., Huppertz, L.M., ‘Psychotropics caught in a trap' - adopting a screening approach to specific needs. Forensic Sci. Int. 243C (2014), 84–89.
61. [61] Broecker, S., Herre, S., Pragst, F., General unknown screening in hair by liquid chromatography-hybrid quadrupole time-of-flight mass spectrometry (lc-qtof-ms). Forensic Sci. Int. 218 (2012), 68–81.
62. [62] Rust, K.Y., Baumgartner, M.R., Meggiolaro, N., Kraemer, T., Detection and validated quantification of 21 benzodiazepines and 3 “z-drugs” in human hair by lc-ms/ms. Forensic Sci. Int. 215 (2012), 64–72.
63. [63] Kole, P.L., Venkatesh, G., Kotecha, J., Sheshala, R., Recent advances in sample preparation techniques for effective bioanalytical methods. Biomed. Chromatogr. 25 (2011), 199–217.
64. [64] Mueller, D.M., Rentsch, K.M., Online extraction toxicological ms(n) screening system for serum and heparinized plasma and comparison of screening results between plasma and urine in the context of clinical data. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 883-884 (2012), 189–197.
65. [65] Periat, A., Kohler, I., Thomas, A., Nicoli, R., Boccard, J., Veuthey, J.L., et al. Systematic evaluation of matrix effects in hydrophilic interaction chromatography versus reversed phase liquid chromatography coupled to mass spectrometry. J. Chromatogr. A, 2015.
66. [66] Croley, T.R., White, K.D., Callahan, J.H., Musser, S.M., The chromatographic role in high resolution mass spectrometry for non-targeted analysis. J. Am. Soc. Mass Spectrom. 23 (2012), 1569–1578.
67. [67] Fekete, S., Olah, E., Fekete, J., Fast liquid chromatography: The domination of core-shell and very fine particles. J. Chromatogr. A 1228 (2012), 57–71.
68. [68] Kohler, I., Guillarme, D., Multi-target screening of biological samples using lc-ms/ms: Focus on chromatographic innovations. Bioanalysis 6 (2014), 1255–1273.
69. [69] Abian, J., Oosterkamp, A.J., Gelpí, E., Comparison of conventional, narrow-bore and capillary liquid chromatography/mass spectrometry for electrospray ionization mass spectrometry: Practical considerations. J. Mass Spectrom. 34 (1999), 244–254.
70. [70] Peters, F.T., Remane, D., Aspects of matrix effects in applications of liquid chromatography-mass spectrometry to forensic and clinical toxicology–a review. Anal. Bioanal. Chem. 403 (2012), 2155–2172.
71. [71] Gosetti, F., Mazzucco, E., Zampieri, D., Gennaro, M.C., Signal suppression/enhancement in high-performance liquid chromatography tandem mass spectrometry. J. Chromatogr. A 1217 (2010), 3929–3937.
72. [72] Tudela, E., Munoz, G., Munoz-Guerra, J.A., Matrix effect marker for multianalyte analysis by lc-ms/ms in biological samples. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 901 (2012), 98–106.
73. [73] Marin, S.J., Sawyer, J.C., He, X., Johnson-Davis, K.L., Comparison of drug detection by three quadrupole time-of-flight mass spectrometry platforms. J. Anal. Toxicol. 39 (2015), 89–95.
74. [74] Sauvage, F.L., Marquet, P., Lc-ms/ms screen for xenobiotics and metabolites. Methods Mol. Biol. 902 (2012), 129–138.
75. [75] European union commission decision 2002/657/ec. Off. J. Eur. Communities, L 221, 2002, 8–36.
76. [76] Guideline on bioanalytical method validation. European Medicines Agency CfMPfHU, Ed., 2012.
77. [77] Broecker, S., Herre, S., Pragst, F., Toxicological screening with the agilent 6500 series accurate-mass q-tof lc/ms and the personal compound database and library using the broecker, herre and pragst accurate mass spectral library. 2010, Agilent Technologies.
78. [78] Oberacher, H., Wiley registry of tandem mass spectral data, ms for id. 2012.
79. [79] Maurer, H.H., Wissenbach, D.K., Weber, A.A., Maurer/wissenbach/weber lc-msn library of drugs, poisons, and their metabolites. 2014, Wiley, Weinheim.
80. [80] Smith, C.A., O'Maille, G., Want, E.J., Qin, C., Trauger, S.A., Brandon, T.R., et al. Metlin: A metabolite mass spectral database. Ther. Drug Monit. 27 (2005), 747–751.
81. [81] Wishart, D.S., Knox, C., Guo, A.C., Eisner, R., Young, N., Gautam, B., et al. Hmdb: A knowledgebase for the human metabolome. Nucleic Acids Res. 37 (2009), D603–D610.
82. [82] Horai, H., Arita, M., Kanaya, S., Nihei, Y., Ikeda, T., Suwa, K., et al. Massbank: A public repository for sharing mass spectral data for life sciences. J. Mass Spectrom. 45 (2010), 703–714.
83. [83] HighChem LLC S. Mzcloud advanced mass spectral database HighChem LLC, Slovakia.
84. [84] Champarnaud, E., Hopley, C., Evaluation of the comparability of spectra generated using a tuning point protocol on twelve electrospray ionisation tandem-in-space mass spectrometers. Rapid Commun. Mass Spectrom. 25 (2011), 1001–1007.
85. [85] Hopley, C., Bristow, T., Lubben, A., Simpson, A., Bull, E., Klagkou, K., et al. Towards a universal product ion mass spectral library - reproducibility of product ion spectra across eleven different mass spectrometers. Rapid Commun. Mass Spectrom. 22 (2008), 1779–1786.
86. [86] Dresen, S., Gergov, M., Politi, L., Halter, C., Weinmann, W., Esi-ms/ms library of 1,253 compounds for application in forensic and clinical toxicology. Anal. Bioanal. Chem. 395 (2009), 2521–2526.
87. [87] Gergov, M., Weinmann, W., Meriluoto, J., Uusitalo, J., Ojanpera, I., Comparison of product ion spectra obtained by liquid chromatography/triple-quadrupole mass spectrometry for library search. Rapid Commun. Mass Spectrom. 18 (2004), 1039–1046.
88. [88] Oberacher, H., Weinmann, W., Dresen, S., Quality evaluation of tandem mass spectral libraries. Anal. Bioanal. Chem. 400 (2011), 2641–2648.
89. [89] Weinmann, W., Stoertzel, M., Vogt, S., Svoboda, M., Schreiber, A., Tuning compounds for electrospray ionization/in-source collision-induced dissociation and mass spectra library searching. J. Mass Spectrom. 36 (2001), 1013–1023.
90. [90] Weinmann, W., Stoertzel, M., Vogt, S., Wendt, J., Tune compounds for electrospray ionisation/in-source collision-induced dissociation with mass spectral library searching. J. Chromatogr. A 926 (2001), 199–209.
91. [91] Jansen, R., Lachatre, G., Marquet, P., Lc-ms/ms systematic toxicological analysis: Comparison of ms/ms spectra obtained with different instruments and settings. Clin. Biochem. 38 (2005), 362–372.
92. [92] Oberacher, H., Pavlic, M., Libiseller, K., Schubert, B., Sulyok, M., Schuhmacher, R., et al. On the inter-instrument and inter-laboratory transferability of a tandem mass spectral reference library: 1. Results of an austrian multicenter study. J. Mass Spectrom. 44 (2009), 485–493.
93. [93] Wissenbach, D.K., Meyer, M.R., Weber, A.A., Remane, D., Ewald, A.H., Peters, F.T., et al. Towards a universal lc-ms screening procedure - can an lit lc-ms(n) screening approach and reference library be used on a quadrupole-lit hybrid instrument?. J. Mass Spectrom. 47 (2012), 66–71.
94. [94] Mylonas, R., Mauron, Y., Masselot, A., Binz, P.A., Budin, N., Fathi, M., et al. X-rank: A robust algorithm for small molecule identification using tandem mass spectrometry. Anal. Chem. 81 (2009), 7604–7610.
95. [95] Oberacher, H., Pavlic, M., Libiseller, K., Schubert, B., Sulyok, M., Schuhmacher, R., et al. On the inter-instrument and the inter-laboratory transferability of a tandem mass spectral reference library: 2. Optimization and characterization of the search algorithm. J. Mass Spectrom. 44 (2009), 494–502.
96. [96] Peters, F.T., Wissenbach, D.K., Systematic toxicological analysis using liquid chromatography-mass spectrometry: Techniques and inter-instrument reproducibility of mass spectra/systematisch-toxikologische analyse mittels hochleistungsflüssigchromatographie-massenspektrometrie: Techniken und reproduzierbarkeit von massenspektren zwischen instrumenten. J. Lab. Med. 36 (2012), 89–97.
97. [97] Bjork, M.K., Simonsen, K.W., Andersen, D.W., Dalsgaard, P.W., Sigurethardottir, S.R., Linnet, K., et al. Quantification of 31 illicit and medicinal drugs and metabolites in whole blood by fully automated solid-phase extraction and ultra-performance liquid chromatography-tandem mass spectrometry. Anal. Bioanal. Chem. 405 (2013), 2607–2617.
98. [98] Steuer, A.E., Forss, A.M., Dally, A.M., Kraemer, T., Method development and validation for simultaneous quantification of 15 drugs of abuse and prescription drugs and 7 of their metabolites in whole blood relevant in the context of driving under the influence of drugs–usefulness of multi-analyte calibration. Forensic Sci. Int. 244 (2014), 92–101.
99. [99] Oiestad, E.L., Johansen, U., Oiestad, A.M., Christophersen, A.S., Drug screening of whole blood by ultra-performance liquid chromatography-tandem mass spectrometry. J. Anal. Toxicol. 35 (2011), 280–293.
100. [100] Saussereau, E., Lacroix, C., Gaulier, J.M., Goulle, J.P., On-line liquid chromatography/tandem mass spectrometry simultaneous determination of opiates, cocainics and amphetamines in dried blood spots. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 885-886 (2012), 1–7.
101. [101] Odoardi, S., Anzillotti, L., Strano-Rossi, S., Simplifying sample pretreatment: Application of dried blood spot (dbs) method to blood samples, including postmortem, for uhplc-ms/ms analysis of drugs of abuse. Forensic Sci. Int. 243 (2014), 61–67.
102. [102] Koster, R.A., Alffenaar, J.W., Greijdanus, B., VanDernagel, J.E., Uges, D.R., Fast and highly selective lc-ms/ms screening for thc and 16 other abused drugs and metabolites in human hair to monitor patients for drug abuse. Ther. Drug Monit. 36 (2014), 234–243.
103. [103] Imbert, L., Dulaurent, S., Mercerolle, M., Morichon, J., Lachatre, G., Gaulier, J.M., Development and validation of a single lc-ms/ms assay following spe for simultaneous hair analysis of amphetamines, opiates, cocaine and metabolites. Forensic Sci. Int. 234 (2014), 132–138.
104. [104] Liu, H.C., Liu, R.H., Lin, D.L., Simultaneous quantitation of amphetamines and opiates in human hair by liquid chromatography-tandem mass spectrometry. J. Anal. Toxicol. 39 (2015), 183–191.
105. [105] Shin, M., Ji, D., Kang, S., Yang, W., Choi, H., Lee, S., Screening of multiple drugs of abuse and metabolites in urine using lc/ms/ms with polarity switching electrospray ionization. Arch. Pharm. Res. 37 (2014), 760–772.
106. [106] Tang, M.H., Ching, C.K., Lee, C.Y., Lam, Y.H., Mak, T.W., Simultaneous detection of 93 conventional and emerging drugs of abuse and their metabolites in urine by uhplc-ms/ms. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 969 (2014), 272–284.
107. [107] Montesano, C., Simeoni, M.C., Curini, R., Sergi, M., Lo Sterzo, C., Compagnone, D., Determination of illicit drugs and metabolites in oral fluid by microextraction on packed sorbent coupled with lc-ms/ms. Anal. Bioanal. Chem. 407 (2015), 3647–3658.
108. [108] Zancanaro, I., Limberger, R.P., Bohel, P.O., Dos Santos, M.K., De Boni, R.B., Pechansky, F., et al. Prescription and illicit psychoactive drugs in oral fluid-lc-ms/ms method development and analysis of samples from brazilian drivers. Forensic Sci. Int. 223 (2012), 208–216.
109. [109] Liu, H.C., Lee, H.T., Hsu, Y.C., Huang, M.H., Liu, R.H., Chen, T.J., et al. Direct injection lc-ms-ms analysis of opiates, methamphetamine, buprenorphine, methadone and their metabolites in oral fluid from substitution therapy patients. J. Anal. Toxicol. 39 (2015), 472–480.
110. [110] de Castro, A., Diaz, A., Pineiro, B., Lendoiro, E., Cruz, A., Lopez-Rivadulla, M., et al. Simultaneous determination of opiates, methadone, amphetamines, cocaine, and metabolites in human placenta and umbilical cord by lc-ms/ms. Anal. Bioanal. Chem. 405 (2013), 4295–4305.
111. [111] Koster, R.A., Alffenaar, J.W., Greijdanus, B., VanDerNagel, J.E., Uges, D.R., Application of sweat patch screening for 16 drugs and metabolites using a fast and highly selective lc-ms/ms method. Ther. Drug Monit. 36 (2014), 35–45.
112. [112] Langman, L.J., Korman, E., Stauble, M.E., Boswell, M.V., Baumgartner, R.N., Jortani, S.A., Therapeutic monitoring of opioids: A sensitive lc-ms/ms method for quantitation of several opioids including hydrocodone and its metabolites. Ther. Drug Monit. 35 (2013), 352–359.
113. [113] Eckart, K., Rohrich, J., Breitmeier, D., Ferner, M., Laufenberg-Feldmann, R., Urban, R., Development of a new multi-analyte assay for the simultaneous detection of opioids in serum and other body fluids using liquid chromatography-tandem mass spectrometry. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 1001 (2015), 1–8.
114. [114] Frost, J., Lokken, T.N., Brede, W.R., Hegstad, S., Nordrum, I.S., Slordal, L., A validated method for simultaneous determination of codeine, codeine-6-glucuronide, norcodeine, morphine, morphine-3-glucuronide and morphine-6-glucuronide in post-mortem blood, vitreous fluid, muscle, fat and brain tissue by lc-ms. J. Anal. Toxicol. 39 (2015), 203–212.
115. [115] Desrosiers, N.A., Scheidweiler, K.B., Huestis, M.A., Quantification of six cannabinoids and metabolites in oral fluid by liquid chromatography-tandem mass spectrometry. Drug Test. Anal. 7 (2015), 684–694.
116. [116] Sauve, E.N., Langodegard, M., Ekeberg, D., Oiestad, A.M., Determination of benzodiazepines in ante-mortem and post-mortem whole blood by solid-supported liquid-liquid extraction and uplc-ms/ms. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 883-884 (2012), 177–188.
117. [117] Mata, D.C., Davis, J.F., Figueroa, A.K., Stanford, M.J., Ultra performance liquid chromatography with tandem mass spectrometry for the quantitation of seventeen sedative hypnotics in six common toxicological matrices. J. Anal. Toxicol., 2015.
118. [118] Montenarh, D., Hopf, M., Maurer, H.H., Schmidt, P., Ewald, A.H., Detection and quantification of benzodiazepines and z-drugs in human whole blood, plasma, and serum samples as part of a comprehensive multi-analyte lc-ms/ms approach. Anal. Bioanal. Chem. 406 (2014), 803–818.
119. [119] Lee, H., Park, Y., Jo, J., In, S., Park, Y., Kim, E., et al. Analysis of benzodiazepines and their metabolites using dbs cards and lc-ms/ms. Forensic Sci. Int. 255 (2015), 137–145.
120. [120] Fisichella, M., Morini, L., Sempio, C., Groppi, A., Validation of a multi-analyte lc-ms/ms method for screening and quantification of 87 psychoactive drugs and their metabolites in hair. Anal. Bioanal. Chem. 406 (2014), 3497–3506.
121. [121] Vogliardi, S., Favretto, D., Tucci, M., Stocchero, G., Ferrara, S.D., Simultaneous lc-hrms determination of 28 benzodiazepines and metabolites in hair. Anal. Bioanal. Chem. 400 (2011), 51–67.
122. [122] Karampela, S., Vardakou, I., Papoutsis, I., Dona, A., Spiliopoulou, C., Athanaselis, S., et al. Direct urine analysis for the identification and quantification of selected benzodiazepines for toxicology screening. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 902 (2012), 42–46.
123. [123] Bertol, E., Vaiano, F., Borsotti, M., Quercioli, M., Mari, F., Comparison of immunoassay screening tests and lc-ms-ms for urine detection of benzodiazepines and their metabolites: Results of a national proficiency test. J. Anal. Toxicol. 37 (2013), 659–664.
124. [124] Verplaetse, R., Henion, J., Quantitative determination of opioids in whole blood using fully automated dried blood spot desorption coupled to on-line spe-lc-ms/ms. Drug Test. Anal., 2015.
125. [125] Eichhorst, J.C., Etter, M.L., Hall, P.L., Lehotay, D.C., Opiate screening and quantitation in urine/blood matrices using lc-ms/ms techniques. Methods Mol. Biol. 902 (2012), 53–64.
126. [126] Saleh, A., Stephanson, N.N., Granelli, I., Villen, T., Beck, O., Evaluation of a direct high-capacity target screening approach for urine drug testing using liquid chromatography-time-of-flight mass spectrometry. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 909 (2012), 6–13.
127. [127] Kim, J., Ji, D., Kang, S., Park, M., Yang, W., Kim, E., et al. Simultaneous determination of 18 abused opioids and metabolites in human hair using lc-ms/ms and illegal opioids abuse proven by hair analysis. J. Pharm. Biomed. Anal. 89 (2014), 99–105.
128. [128] Montenarh, D., Hopf, M., Maurer, H.H., Schmidt, P., Ewald, A.H., Development and validation of a multi-analyte lc-ms/ms approach for quantification of neuroleptics in whole blood, plasma, and serum. Drug Test. Anal., 2015.
129. [129] Patteet, L., Maudens, K.E., Sabbe, B., Morrens, M., De Doncker, M., Neels, H., High throughput identification and quantification of 16 antipsychotics and 8 major metabolites in serum using ultra-high performance liquid chromatography-tandem mass spectrometry. Clin. Chim. Acta Int. J. Clin. Chem. 429 (2014), 51–58.
130. [130] Fisher, D.S., Partridge, S.J., Handley, S.A., Couchman, L., Morgan, P.E., Flanagan, R.J., Lc-ms/ms of some atypical antipsychotics in human plasma, serum, oral fluid and haemolysed whole blood. Forensic Sci. Int. 229 (2013), 145–150.
131. [131] Steuer, A.E., Poetzsch, M., Koenig, M., Tingelhoff, E., Staeheli, S.N., Roemmelt, A.T., et al. Comparison of conventional liquid chromatography-tandem mass spectrometry versus microflow liquid chromatography-tandem mass spectrometry within the framework of full method validation for simultaneous quantification of 40 antidepressants and neuroleptics in whole blood. J. Chromatogr. A 1381 (2015), 87–100.
132. [132] Berm, E.J., Paardekooper, J., Brummel-Mulder, E., Hak, E., Wilffert, B., Maring, J.G., A simple dried blood spot method for therapeutic drug monitoring of the tricyclic antidepressants amitriptyline, nortriptyline, imipramine, clomipramine, and their active metabolites using lc-ms/ms. Talanta 134 (2015), 165–172.
133. [133] Santos, M.G., Tavares, I.M., Boralli, V.B., Figueiredo, E.C., Direct doping analysis of beta-blocker drugs from urinary samples by on-line molecularly imprinted solid-phase extraction coupled to liquid chromatography/mass spectrometry. Analyst 140 (2015), 2696–2703.
134. [134] Mazzarino, M., Fiacco, I., de la Torre, X., Botre, F., Screening and confirmation analysis of stimulants, narcotics and beta-adrenergic agents in human urine by hydrophilic interaction liquid chromatography coupled to mass spectrometry. J. Chromatogr. A 1218 (2011), 8156–8167.
135. [135] Lawson, A.J., Shipman, K.E., George, S., Dasgupta, I., A novel ‘dilute-and-shoot' liquid chromatography-tandem mass spectrometry method for the screening of antihypertensive drugs in urine. J. Anal. Toxicol., 2015.
136. [136] Rust, K.Y., Wilkens, H., Kaiser, R., Bregel, D., Wilske, J., Kraemer, T., Detection and validated quantification of the phosphodiesterase type 5 inhibitors sildenafil, vardenafil, tadalafil, and 2 of their metabolites in human blood plasma by lc-ms/ms–application to forensic and therapeutic drug monitoring cases. Ther. Drug Monit. 34 (2012), 729–735.
137. [137] Lee, S., Choi, B., Kim, J., In, S., Baeck, S., Oh, S.M., et al. An lc-ms/ms method for the determination of five erectile dysfunction drugs and their selected metabolites in hair. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 978-979 (2015), 1–10.
138. [138] Binz, T.M., Villani, N., Neels, H., Schneider, S., Rapid extraction, identification and quantification of oral hypoglycaemic drugs in serum and hair using lc-ms/ms. Forensic Sci. Int. 223 (2012), 119–124.
139. [139] Hess, C., Musshoff, F., Madea, B., Simultaneous identification and validated quantification of 11 oral hypoglycaemic drugs in plasma by electrospray ionisation liquid chromatography-mass spectrometry. Anal. Bioanal. Chem. 400 (2011), 33–41.
140. [140] Chambers, E.E., Fountain, K.J., Smith, N., Ashraf, L., Karalliedde, J., Cowan, D., et al. Multidimensional lc-ms/ms enables simultaneous quantification of intact human insulin and five recombinant analogs in human plasma. Anal. Chem. 86 (2014), 694–702.
141. [141] Hess, C., Thomas, A., Thevis, M., Stratmann, B., Quester, W., Tschoepe, D., et al. Simultaneous determination and validated quantification of human insulin and its synthetic analogues in human blood serum by immunoaffinity purification and liquid chromatography-mass spectrometry. Anal. Bioanal. Chem. 404 (2012), 1813–1822.
142. [142] Thomas, A., Schanzer, W., Thevis, M., Determination of human insulin and its analogues in human blood using liquid chromatography coupled to ion mobility mass spectrometry (lc-im-ms). Drug Test. Anal. 6 (2014), 1125–1132.
143. [143] Strano-Rossi, S., Odoardi, S., Fisichella, M., Anzillotti, L., Gottardo, R., Tagliaro, F., Screening for new psychoactive substances in hair by ultrahigh performance liquid chromatography-electrospray ionization tandem mass spectrometry. J. Chromatogr. A 1372C (2014), 145–156.
144. [144] Scheidweiler, K.B., Huestis, M.A., Simultaneous quantification of 20 synthetic cannabinoids and 21 metabolites, and semi-quantification of 12 alkyl hydroxy metabolites in human urine by liquid chromatography-tandem mass spectrometry. J. Chromatogr. A 1327 (2014), 105–117.
145. [145] Ammann, J., McLaren, J.M., Gerostamoulos, D., Beyer, J., Detection and quantification of new designer drugs in human blood: Part 1 - synthetic cannabinoids. J. Anal. Toxicol. 36 (2012), 372–380.
146. [146] Ambach, L., Redondo, A.H., Konig, S., Angerer, V., Schurch, S., Weinmann, W., Detection and quantification of 56 new psychoactive substances in whole blood and urine by lc-ms/ms. Bioanalysis 7 (2015), 1119–1136.
147. [147] Nieddu, M., Burrai, L., Demontis, M.P., Varoni, M.V., Baralla, E., Trignano, C., et al. Simultaneous determination of 11 illicit phenethylamines in hair by lc-ms-ms: In vivo application. J. Anal. Toxicol. 39 (2015), 532–537.
148. [148] Al-Saffar, Y., Stephanson, N.N., Beck, O., Multicomponent lc-ms/ms screening method for detection of new psychoactive drugs, legal highs, in urine-experience from the swedish population. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 930 (2013), 112–120.
149. [149] Kerrigan, S., Mott, A., Jatzlau, B., Ortiz, F., Perrella, L., Martin, S., et al. Designer psychostimulants in urine by liquid chromatography-tandem mass spectrometry. J. Forensic Sci. 59 (2014), 175–183.
150. [150] Concheiro, M., Anizan, S., Ellefsen, K., Huestis, M.A., Simultaneous quantification of 28 synthetic cathinones and metabolites in urine by liquid chromatography-high resolution mass spectrometry. Anal. Bioanal. Chem. 405 (2013), 9437–9448.
151. [151] Ammann, D., McLaren, J.M., Gerostamoulos, D., Beyer, J., Detection and quantification of new designer drugs in human blood: Part 2 - designer cathinones. J. Anal. Toxicol. 36 (2012), 381–389.
152. [152] Martin, R., Schurenkamp, J., Gasse, A., Pfeiffer, H., Kohler, H., Determination of psilocin, bufotenine, lsd and its metabolites in serum, plasma and urine by spe-lc-ms/ms. Int. J. Legal Med. 127 (2013), 593–601.
153. [153] Zhai, J.X., Shen, M., Liu, W., Simultaneous screening for 45 poisonous alkaloids in blood by lc-ms/ms. Fa Yi Xue Za Zhi 31 (2015), 28–33.
154. [154] Luzardo, O.P., Almeida-Gonzalez, M., Ruiz-Suarez, N., Zumbado, M., Henriquez-Hernandez, L.A., Meilan, M.J., et al. Validated analytical methodology for the simultaneous determination of a wide range of pesticides in human blood using gc-ms/ms and lc-esi/ms/ms and its application in two poisoning cases. Sci. Justice J. Forensic Sci. Soc. 55 (2015), 307–315.
155. [155] Kumari, R., Patel, D.K., Panchal, S., Jha, R.R., Satyanarayana, G.N., Asati, A., et al. Fast agitated directly suspended droplet microextraction technique for the rapid analysis of eighteen organophosphorus pesticides in human blood. J. Chromatogr. A 1377 (2015), 27–34.
156. [156] Bidny, S., Gago, K., David, M., Duong, T., Albertyn, D., Gunja, N., A validated lc-ms-ms method for simultaneous identification and quantitation of rodenticides in blood. J. Anal. Toxicol. 39 (2015), 219–224.
157. [157] Shah, I., Petroczi, A., Uvacsek, M., Ranky, M., Naughton, D.P., Hair-based rapid analyses for multiple drugs in forensics and doping: Application of dynamic multiple reaction monitoring with lc-ms/ms. Chem. Cent. J., 8, 2014, 73.
158. [158] Di Rago, M., Saar, E., Rodda, L.N., Turfus, S., Kotsos, A., Gerostamoulos, D., et al. Fast targeted analysis of 132 acidic and neutral drugs and poisons in whole blood using lc-ms/ms. Forensic Sci. Int. 243 (2014), 35–43.
159. [159] Remane, D., Wetzel, D., Peters, F.T., Development and validation of a liquid chromatography-tandem mass spectrometry (lc-ms/ms) procedure for screening of urine specimens for 100 analytes relevant in drug-facilitated crime (dfc). Anal. Bioanal. Chem. 406 (2014), 4411–4424.
160. [160] Staeheli, S.N., Poetzsch, M., Kraemer, T., Steuer, A.E., Development and validation of a dynamic range-extended lc-ms/ms multi-analyte method for 11 different postmortem matrices for redistribution studies applying solvent calibration and additional (13)c isotope monitoring. Anal. Bioanal. Chem. 407 (2015), 8681–8712.
161. [161] Dong, Y., Yan, K., Ma, Y., Wang, S., He, G., Deng, J., et al. A sensitive dilute-and-shoot approach for the simultaneous screening of 71 stimulants and 7 metabolites in human urine by lc-ms-ms with dynamic mrm. J. Chromatogr. Sci. 53 (2015), 1528–1535.
162. [162] Lee, K.M., Kim, H.J., Jeong, E.S., Yoo, H.H., Kwon, O.S., Jin, C., et al. Simple and accurate quantitative analysis of seven prohibited threshold substances in human urine by liquid chromatography/tandem mass spectrometry in doping control. Rapid Commun. Mass Spectrom. 25 (2011), 2261–2267.
163. [163] Andersen, D.W., Linnet, K., Screening for anabolic steroids in urine of forensic cases using fully automated solid phase extraction and lc-ms-ms. J. Anal. Toxicol. 38 (2014), 637–644.
164. [164] Tudela, E., Deventer, K., Geldof, L., Van Eenoo, P., Urinary detection of conjugated and unconjugated anabolic steroids by dilute-and-shoot liquid chromatography-high resolution mass spectrometry. Drug Test. Anal. 7 (2015), 95–108.
165. [165] Ahi, S., Beotra, A., Dubey, S., Upadhyay, A., Jain, S., Simultaneous identification of prednisolone and its ten metabolites in human urine by high performance liquid chromatography-tandem mass spectrometry. Drug Test. Anal. 4 (2012), 460–467.
166. [166] Wagner, M., Tonoli, D., Varesio, E., Hopfgartner, G., The use of mass spectrometry to analyze dried blood spots. Mass Spectrom. Rev. 35 (2016), 361–438.
167. [167] Wilhelm, A.J., den Burger, J.C., Swart, E.L., Therapeutic drug monitoring by dried blood spot: Progress to date and future directions. Clin. Pharmacokinet. 53 (2014), 961–973.
168. [168] Cuypers, E., Flinders, B., Boone, C.M., Bosman, I.J., Lusthof, K.J., Van Asten, A.C., et al. Consequences of decontamination procedures in forensic hair analysis using metal-assisted secondary ion mass spectrometry analysis. Anal. Chem. 88 (2016), 3091–3097.
169. [169] Sampedro, M.C., Unceta, N., Gomez-Caballero, A., Callado, L.F., Morentin, B., Goicolea, M.A., et al. Screening and quantification of antipsychotic drugs in human brain tissue by liquid chromatography-tandem mass spectrometry: Application to postmortem diagnostics of forensic interest. Forensic Sci. Int. 219 (2012), 172–178.
170. [170] Matsuta, S., Nakanishi, K., Miki, A., Zaitsu, K., Shima, N., Kamata, T., et al. Development of a simple one-pot extraction method for various drugs and metabolites of forensic interest in blood by modifying the quechers method. Forensic Sci. Int. 232 (2013), 40–45.
171. [171] Identification criteria for qualitative assays. Incorporating chromatography and mass spectrometry, 2003, WADA Technical Document - TD2003IDCR: WADA - World Anti-Doping Agency.
172. [172] Freijo, T.D. Jr., Harris, S.E., Kala, S.V., A rapid quantitative method for the analysis of synthetic cannabinoids by liquid chromatography-tandem mass spectrometry. J. Anal. Toxicol. 38 (2014), 466–478.
173. [173] Hsu, K.F., Chien, K.Y., Chang-Chien, G.P., Lin, S.F., Hsu, P.H., Hsu, M.C., Liquid chromatography-tandem mass spectrometry screening method for the simultaneous detection of stimulants and diuretics in urine. J. Anal. Toxicol. 35 (2011), 665–674.
174. [174] Peters, F.T., Stability of analytes in biosamples - an important issue in clinical and forensic toxicology?. Anal. Bioanal. Chem. 388 (2007), 1505–1519.
175. [175] Remane, D., Meyer, M.R., Wissenbach, D.K., Maurer, H.H., Ion suppression and enhancement effects of co-eluting analytes in multi-analyte approaches: Systematic investigation using ultra-high-performance liquid chromatography/mass spectrometry with atmospheric-pressure chemical ionization or electrospray ionization. Rapid Commun. Mass Spectrom. 24 (2010), 3103–3108.
176. [176] Remane, D., Wissenbach, D.K., Meyer, M.R., Maurer, H.H., Systematic investigation of ion suppression and enhancement effects of fourteen stable-isotope-labeled internal standards by their native analogues using atmospheric-pressure chemical ionization and electrospray ionization and the relevance for multi-analyte liquid chromatographic/mass spectrometric procedures. Rapid Commun. Mass Spectrom. 24 (2010), 859–867.
177. [177] Montenarh, D., Wernet, M.P., Hopf, M., Maurer, H.H., Schmidt, P.H., Ewald, A.H., Quantification of 33 antidepressants by lc-ms/ms-comparative validation in whole blood, plasma, and serum. Anal. Bioanal. Chem. 406 (2014), 5939–5953.
178. [178] Jeon, B.W., Yoo, H.H., Jeong, E.S., Kim, H.J., Jin, C., Kim, D.H., et al. Lc-esi/ms/ms method for rapid screening and confirmation of 44 exogenous anabolic steroids in human urine. Anal. Bioanal. Chem. 401 (2011), 1353–1363.
179. [179] Luzardo, O.P., Ruiz-Suarez, N., Valeron, P.F., Camacho, M., Zumbado, M., Henriquez-Hernandez, L.A., et al. Methodology for the identification of 117 pesticides commonly involved in the poisoning of wildlife using gc-ms-ms and lc-ms-ms. J. Anal. Toxicol. 38 (2014), 155–163.
180. [180] Wang, J., Yang, Z., Lechago, J., Rapid and simultaneous determination of multiple classes of abused drugs and metabolites in human urine by a robust lc-ms/ms method - application to urine drug testing in pain clinics. Biomed. Chromatogr. 27 (2013), 1463–1480.
181. [181] Eichhorst, J.C., Etter, M.L., Hall, P.L., Lehotay, D.C., Lc-ms/ms techniques for high-volume screening of drugs of abuse and target drug quantitation in urine/blood matrices. Methods Mol. Biol. 902 (2012), 29–41.
182. [182] Maublanc, J., Dulaurent, S., Morichon, J., Lachatre, G., Gaulier, J.M., Identification and quantification of 35 psychotropic drugs and metabolites in hair by lc-ms/ms: Application in forensic toxicology. Int. J. Legal Med. 129 (2015), 259–268.
183. [183] Baumgartner, M.R., Guglielmello, R., Fanger, M., Kraemer, T., Analysis of drugs of abuse in hair: Evaluation of the immunochemical method vma-t vs. Lc-ms/ms or gc-ms. Forensic Sci. Int. 215 (2012), 56–59.